Senior insider sale
CMO at EDGEWISE THERAPEUTICS, INC. — senior position signals high conviction
$2.27M
71.59K shares
What this filing means
DONOVAN JOANNE M. plans to sell 71.59K shares of EDGEWISE THERAPEUTICS, INC. valued at approximately $2.27M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/27/2026ACC: 0001950047-26-003048
Officer· CMO
Since Apr 2021
71.59K
Shares to sell
$2.27M
Approx. market value
71.59K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Exercise of Stock Options
Cash
3/27/2026
50KRestricted Stock Units
N/A
5/1/2024
11.96KEmployee Stock Purchase Plan
Cash
5/15/2022
9.62KTotal acquired71.59K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/27/2026 | Exercise of Stock Options Cash | 50K | — |
5/1/2024 | Restricted Stock Units N/A | 11.96K | — |
5/15/2022 | Employee Stock Purchase Plan Cash | 9.62K | — |
| Total | 71.59K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
71.59K
Market value
$2.27M
3/27/2026
Total
Units
71.59K
Value
$2.27M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/27/2026 | 71.59K | $2.27M | NASDAQ | Planned |
| Total | 71.59K | $2.27M | ||